-
Part 1 | Session 1 View from the Thoraxcenter: What's Hot at ACC.25?
-
Part 1 | Session 2 View from the Thoraxcenter: ACC 25 Wrap-Up
-
Part 2 | Session 1 ADVANCE-HTN: Lorundrostat in Patients with Uncontrolled Hypertension
-
Part 2 | Session 2 STRIDE: Semaglutide for Functional Capacity in Patients with T2D and PAD
-
Part 2 | Session 3 API-CAT: Reduced Vs Full Dose Apixaban for Cancer-Associated Thrombosis
-
Part 2 | Session 4 FRESH-UP: Liberal Intake Vs Fluid Restriction in Chronic Heart Failure
-
Part 2 | Session 5 SOUL: Semaglutide in Patients with T2D
-
Part 2 | Session 6 BHF PROTECT-TAVI: Cerebral Embolic Protection in TAVI
-
Part 3 | Session 1 The Phase 3 REVERSE-IT Trial
-
Part 3 | Session 2 EVOLUT Low Risk: 5Y Outcomes After TAVR or SAVR in Low-Risk Patients with AS
-
Part 3 | Session 3 SMART-CHOICE 3: Clopidogrel vs Aspirin Monotherapy in High-Risk PCI Patients
-
Part 3 | Session 6 MIGHTy-Heart: Mobile Integrated Health in Heart Failure
-
Part 3 | Session 10 Lifetime Benefit by Control of Modifiable Risk Factors
-
Part 3 | Session 11 CardiAMP-HF: Autologous Cell Therapy in Patients With HFrEF
-
Part 4 | Session 1 4 Trials That Will Change My Practice with Dr Ambarish Pandey
ACC 2025 - In this succinct video, Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute & University of California, CA, US) outlines the key late-breaking trials from the conference that are expected to have an impact on clinical practice.
Trials covered in detail include:
FRESH-UP
API-CAT
ALIGN-AR
PROTECT-TAVI
Recorded on-site at ACC in Chicago, 2025.
Support: This is an independent interview produced by Radcliffe Cardiology.
Keep up-to-date with our video collection on the American College of Cardiology's 74th annual congress, covering late-breaking science, featured science and clinical horizon sessions. Don't miss the preview and wrap-up of the congress in our View From the Thoraxcenter series, concise Expert Interviews with select faculty offering take-home messages for practice, and our Highlights summarising the most influential trials.
More from this programme
Faculty Biographies

Dipti Itchhaporia
Interventional Cardiologist
Dr Dipti Itchhaporia, an interventional cardiologist, holds the Eric & Sheila Samson Endowed Chair in Cardiovascular Health and serves as the director of disease management for the Hoag Heart and Vascular Institute. Additionally, she is an Associate Clinical Professor at the University of California, Irvine, and a Past President of the American College of Cardiology (ACC).
Dr Itchhaporia completed her residency in internal medicine at Stanford University Medical Center. She then joined the General Medicine Faculty at the University of California, San Francisco (UCSF) but eventually pursued a cardiology fellowship at Georgetown University and an interventional cardiology fellowship at Stanford University. She is a fellow of the American College of Cardiology, the European Society of Cardiology, and an honorary member of the British Cardiovascular Society.
Comments